PL EN


Preferences help
enabled [disable] Abstract
Number of results
2016 | 63 | 3 | 475-482
Article title

Endothelial progenitor cells participation in cardiovascular and kidney diseases: a systematic review

Content
Title variants
Languages of publication
EN
Abstracts
EN
Endothelial progenitor cells (EPCs) represent a small population of blood cells (5-40 cells/mm3), with an ability to differentiate into endothelial cells that form the lining of the blood vessels and contribute to postnatal angiogenesis. Abundant evidence shows that recruitment of EPCs from the bone marrow, the monocyte/macrophage lineage and the organs facilitate the endothelial regeneration and repair. Changes in the number of EPCs were observed in both, chronic kidney and cardiovascular diseases. Thus, these cells were tested for usage in diagnosis and therapy. In this paper, we review the current knowledge on the EPC biology and contribution of these cells to the kidney and cardiovascular diseases.
Publisher

Year
Volume
63
Issue
3
Pages
475-482
Physical description
Dates
published
2016
received
2016-03-07
revised
2016-05-05
accepted
2016-05-18
(unknown)
2016-07-30
Contributors
  • Faculty of Medical Sciences, Department of Human Histology and Embryology, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland
  • Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Poland
  • Faculty of Medical Sciences Department of Nephrology, Hypertension and Internal Medicine, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland
  • Faculty of Medical Sciences, Department of Human Histology and Embryology, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland
  • Faculty of Medical Sciences Department of Nephrology, Hypertension and Internal Medicine, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland
References
  • Aird WC (2012) Endothelial cell heterogeneity. Cold Spring Harb Perspect Med 2: a006429. doi: 10.1101/cshperspect.a006429.
  • Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967. doi: 10.1126/science.275.5302.964.
  • Bahlmann FH, De Groot K, Spandau JM, Landry AL, Hertel B, Duckert T, Boehm SM, Menne J, Haller H, Fliser D (2004) Erythropoietin regulates endothelial progenitor cells. Blood 103: 921-926. doi: 10.1182/blood-2003-04-1284.
  • Bahlman FH, Speer T, Fliser D (2010) Endothelial progenitor cells in chronic kidney disease. Nephrol Dial Transplant 25: 341-346. doi: 10.1093/ndt/gfp643.
  • Banerjee S, Xu H, Fuh E, Nguyen KT, Garcia JA, Brilakis ES, Bhatt DL (2012) Endothelial progenitor cell response to antiproliferative drug exposure. Atherosclerosis 225: 91-98. doi: 10.1016/j.atherosclerosis.2012.08.025.
  • Caplice NM, Doyle B (2005) Vascular progenitor cells: origin and mechanisms of mobilization, differentiation, integration, and vasculogenesis. Stem Cells Dev 14: 122-139. doi: 10.1089/scd.2005.14.122.
  • Carracedo J, Merino A, Briceño C, Soriano S, Buendía P, Calleros L, Rodriguez M, Martín-Malo A, Aljama P, Ramírez R (2011) Carbamylated low-density lipoprotein induces oxidative stress and accelerated senescence in human endothelial progenitor cells. FASEB J 25: 1314-1322. doi: 10.1096/fj.10-173377.
  • Chade AR, Zhu XY, Krier JD, Jordan KL, Textor SC, Grande JP, Lerman A, Lerman LO (2010) Endothelial progenitor cells homing and renal repair in experimental renovascular disease. Stem Cells 28: 1039-1047. doi: 10.1002/stem.426.
  • Chen YT, Cheng BC, Ko SF, Chen CH, Tsai TH, Leu S, Chang HW, Chung SY, Chua S, Yeh KH, Chen YL, Yip HK (2013) Value and level of circulating endothelial progenitor cells, angiogenesis factors and mononuclear cell apoptosis in patients with chronic kidney disease. Clin Exp Nephrol 17: 83-91. doi: 10.1007/s10157-012-0664-9.
  • Chen Z, Herrmann SM, Zhu X, Jordan KL, Gloviczki ML, Lerman A, Textor SC, Lerman LO (2014) Preserved function of late-outgrowth endothelial cells in medically treated hypertensive patients under well-controlled conditions. Hypertension 64: 808-814. doi: 10.1161/HYPERTENSIONAHA.114.03720.
  • Dalrymple LS, Katz R, Kestenbaum B, Shlipak MG, Sarnak MJ, Stehman-Breen C, Seliger S, Siscovick D, Newman AB, Fried L (2011) Chronic kidney disease and the risk of end-stage renal disease versus death. J Gen Intern Med 26: 379-385. doi: 10.1007/s11606-010-1511-x.
  • de Groot K, Bahlmann FH, Sowa J, Koenig J, Menne J, Haller H, Fliser D (2004) Uremia causes endothelial progenitor cell deficiency. Kidney Int 66: 641-646. doi: 10.1111/j.1523-1755.2004.00784.x.
  • de Groot K, Bahlmann FH, Bahlmann E, Menne J, Haller H, Fliser D (2005) Kidney graft function determines endothelial progenitor cell number in renal transplant recipients. Transplantation 79: 941-945.
  • Di Marco GS, Rustemeyer P, Brand M, Koch R, Kentrup D, Grabner A, Greve B, Wittkowski W, Pavenstädt H, Hausberg M, Reuter S, Lang D (2011) Circulating endothelial progenitor cells in kidney transplant patients. PLoS One 6: e24046. doi: 10.1371/journal.pone.0024046.
  • Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, Rütten H, Fichtlscherer S, Martin H, Zeiher AM (2001) HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 108: 391-397. doi: 10.1172/JCI13152.
  • Dong L, Kang L, Ding L, Chen Q, Bai J, Gu R, Li L, Xu B (2011) Insulin modulates ischemia-induced endothelial progenitor cell mobilization and neovascularization in diabetic mice. Microvasc Res 82: 227-236. doi: 10.1016/j.mvr.2011.09.006.
  • Endtmann C, Ebrahimian T, Czech T, Arfa O, Laufs U, Fritz M, Wassmann K, Werner N, Petoumenos V, Nickenig G, Wassmann S (2011) Angiotensin II impairs endothelial progenitor cell number and function in vitro and in vivo: implications for vascular regeneration. Hypertension 58: 394-403. doi: 10.1161/HYPERTENSIONAHA.110.169193.
  • Fadini GP, Coracina A, Baesso I, Agostini C, Tiengo A, Avogaro A, de Kreutzenberg SV (2006) Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. Stroke 37: 2277-2282. doi: 10.1161/01.STR.0000236064.19293.79.
  • Fadini GP, de Kreutzenberg S, Albiero M, Coracina A, Pagnin E, Baesso I, Cignarella A, Bolego C, Plebani M, Nardelli GB, Sartore S, Agostini C, Avogaro A (2008) Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. Arterioscler Thromb Vasc Biol 28: 997-1004. doi: 10.1161/ATVBAHA.107.159558.
  • Fatini C, Sticchi E, Cesari F, Gori AM, Cioni G, De Stefano M, Bertoni E, Paudice N, Salvadori M, Zanazzi M, Abbate R (2012) Relationship among endothelial response to hyperemia, bone marrow-derived progenitor cells, and parathyroid hormone in renal transplantation. Transplantation 93: 835-841. doi: 10.1097/TP.0b013e318247a75d.
  • Friedrich EB, Walenta K, Scharlau J, Nickenig G, Werner N (2006) CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ Res 98: e20-5. doi: 10.1161/01.RES.0000205765.28940.93.
  • Giannotti G, Doerries C, Mocharla PS, Mueller MF, Bahlmann FH, Horvàth T, Jiang H, Sorrentino SA, Steenken N, Manes C, Marzilli M, Rudolph KL, Lüscher TF, Drexler H, Landmesser U (2010) Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction. Hypertension 55: 1389-1397. doi: 10.1161/HYPERTENSIONAHA.109.141614.
  • Goligorsky MS, Yasuda K, Ratliff B (2010) Dysfunctional endothelial progenitor cells in chronic kidney disease. J Am Soc Nephrol 21: 911-919. doi: 10.1681/ASN.2009111119.
  • Goligorsky MS (2014) Endothelial progenitor cells: from senescence to rejuvenation. Semin Nephrol 34: 365-373. doi: 10.1016/j.semnephrol.2014.06.003.
  • Herbrig K, Gebler K, Oelschlaegel U, Pistrosch F, Foerster S, Wagner A, Gross P, Passauer J (2006) Kidney transplantation substantially improves endothelial progenitor cell dysfunction in patients with end-stage renal disease. Am J Transplant 6: 2922-2928. doi: 10.1111/j.1600-6143.2006.01555.x.
  • Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593-600. doi: 10.1056/NEJMoa022287.
  • Hillebrands JL, Klatter FA, van Dijk WD, Rozing J (2002) Bone marrow does not contribute substantially to endothelial-cell replacement in transplant arteriosclerosis. Nat Med 8: 194-195. doi: 10.1038/nm0302-194.
  • Hoffmann BR, Wagner JR, Prisco AR, Janiak A, Greene AS (2013) Vascular endothelial growth factor-A signaling in bone marrow-derived endothelial progenitor cells exposed to hypoxic stress. Physiol Genomics 45: 1021-1034. doi: 10.1152/physiolgenomics.00070.2013.
  • Hsu CY, Huang PH, Chiang CH, Leu HB, Huang CC, Chen JW, Lin SJ (2013) Increased circulating endothelial apoptotic microparticle to endothelial progenitor cell ratio is associated with subsequent decline in glomerular filtration rate in hypertensive patients. PLoS One 8: e68644. doi: 10.1371/journal.pone.0068644.
  • Huang PH, Huang SS, Chen YH, Lin CP, Chiang KH, Chen JS, Tsai HY, Lin FY, Chen JW, Lin SJ (2010) Increased circulating CD31+/annexin V+ apoptotic microparticles and decreased circulating endothelial progenitor cell levels in hypertensive patients with microalbuminuria. J Hypertens 28: 1655-1656. doi: 10.1097/HJH.0b013e32833a4d0a.
  • Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, Pollok K, Ferkowicz MJ, Gilley D, Yoder MC (2004) Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104: 2752-2760. doi: 10.1182/blood-2004-04-1396.
  • Jie KE, Zaikova MA, Bergevoet MW, Westerweel PE, Rastmanesh M, Blankestijn PJ, Boer WH, Braam B, Verhaar MC (2010) Progenitor cells and vascular function are impaired in patients with chronic kidney disease. Nephrol Dial Transplant 25: 1875-1882. doi: 10.1093/ndt/gfp749.
  • Jourde-Chiche N, Dou L, Sabatier F, Calaf R, Cerini C, Robert S, Camoin-Jau L, Charpiot P, Argiles A, Dignat-George F, Brunet P (2009) Levels of circulating endothelial progenitor cells are related to uremic toxins and vascular injury in hemodialysis patients. J Thromb Haemost 7: 1576-1584. doi: 10.1111/j.1538-7836.2009.03540.x.
  • Jourde-Chiche N, Dou L, Cerini C, Dignat-George F, Brunet P (2011) Vascular incompetence in dialysis patients--protein-bound uremic toxins and endothelial dysfunction. Semin Dial 24: 327-337. doi: 10.1111/j.1525-139X.2011.00925.x.
  • Krenning G, Dankers PY, Drouven JW, Waanders F, Franssen CF, van Luyn MJ, Harmsen MC, Popa ER (2009) Endothelial progenitor cell dysfunction in patients with progressive chronic kidney disease. Am J Physiol Renal Physiol 296: F1314-1322. doi: 10.1152/ajprenal.90755.2008.
  • Krieter DH, Fischer R, Merget K, Lemke HD, Morgenroth A, Canaud B, Wanner C (2010) Endothelial progenitor cells in patients on extracorporeal maintenance dialysis therapy. Nephrol Dial Transplant 25: 4023-4031. doi: 10.1093/ndt/gfq552.
  • Liang CJ, Shen WC, Chang FB, Wu VC, Wang SH, Young GH, Tsai JS, Tseng YC, Peng YS, Chen YL (2015) Endothelial progenitor cells derived from Wharton's jelly of human umbilical cord attenuate ischemic acute kidney injury by increasing vascularization and decreasing apoptosis, inflammation, and fibrosis. Cell Transplant 24: 1363-1377. doi: 10.3727/096368914X681720.
  • Laschke MW, Giebels C, Menger MD (2011) Vasculogenesis: a new piece of the endometriosis puzzle. Hum Reprod Update 17: 628-636. doi: 10.1093/humupd/dmr023.
  • Lau KK, Chan YH, Yiu KH, Li SW, Tam S, Lau CP, Kwong YL, Tse HF (2007) Burden of carotid atherosclerosis in patients with stroke: relationships with circulating endothelial progenitor cells and hypertension. J Hum Hypertens 21: 445-451. doi: 10.1038/sj.jhh.1002178.
  • Laufs U, Werner N, Link A, Endres M, Wassmann S, Jürgens K, Miche E, Böhm M, Nickenig G (2004) Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 109: 220-226. doi: 10.1161/01.CIR.0000109141.48980.37.
  • Lin Y, Weisdorf DJ, Solovey A, Hebbel RP (2000) Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105: 71-77. doi: 10.1172/JCI8071.
  • Maezawa Y, Takemoto M, Yokote K (2015) Cell biology of diabetic nephropathy: Roles of endothelial cells, tubulointerstitial cells and podocytes. J Diabetes Investig 6: 3-15. doi: 10.1111/jdi.12255.
  • Maruyama S, Taguchi A, Iwashima S, Ozaki T, Yasuda K, Kikuchi-Taura A, Soma T, Ishii H, Murohara T, Takahashi H, Kasuga H, Kumada Y, Toriyama T, Ito Y, Kawahara H, Yuzawa Y, Matsuo S (2008) Low circulating CD34+ cell count is associated with poor prognosis in chronic hemodialysis patients. Kidney Int 74: 1603-1609. doi: 10.1038/ki.2008.495.
  • O'Hare AM, Choi AI, Bertenthal D, Bacchetti P, Garg AX, Kaufman JS, Walter LC, Mehta KM, Steinman MA, Allon M, McClellan WM, Landefeld CS (2007) Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 18: 2758-2765. doi: 10.1681/ASN.2007040422.
  • Park YJ, Kim JY, Park J, Choi JJ, Kim WU, Cho CS (2014) Bone erosion is associated with reduction of circulating endothelial progenitor cells and endothelial dysfunction in rheumatoid arthritis. Arthritis Rheumatol 66: 1450-1460.
  • Patschan SA, Patschan D, Temme J, Korsten P, Wessels JT, Koziolek M, Henze E, Müller GA (2011) Endothelial progenitor cells (EPC) in sepsis with acute renal dysfunction (ARD). Crit Care 15: R94. doi: 10.1186/cc10100.
  • Pistrosch F, Herbrig K, Oelschlaegel U, Richter S, Passauer J, Fischer S, Gross P (2005) PPARgamma-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells. Atherosclerosis 183: 163-167. doi: j.atherosclerosis.2005.03.039.
  • Ratliff BB, Goligorsky MS (2013) Delivery of EPC embedded in HA-hydrogels for treatment of acute kidney injury. Biomatter 3: e23284. http://dx.doi.org /10.4161/biom.23284.
  • Ribeiro V, Bosquetti B, Gonçalves SM, Bucharles SG, Rempel L, Maciel RA, de Oliveira RB, Pecoits-Filho R, Stinghen AE (2014) Uremic serum inhibits in vitro expression of chemokine SDF-1: impact of uremic toxicity on endothelial injury. J Bras Nefrol 36: 123-131. doi: 10.5935/0101-2800.20140021.
  • Rifkin DE, Katz R, Chonchol M, Fried LF, Cao J, de Boer IH, Siscovick DS, Shlipak MG, Sarnak MJ (2010) Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly. Nephrol Dial Transplant 25: 1560-1567. doi: 10.1093/ndt/gfp646.
  • Satoh M, Minami Y, Takahashi Y, Tabuchi T, Itoh T, Nakamura M (2009) Effect of intensive lipid-lowering therapy on telomere erosion in endothelial progenitor cells obtained from patients with coronary artery disease. Clin Sci (Lond) 116: 827-835. doi: 10.1042/CS20080404.
  • Schlieper G, Hristov M, Brandenburg V, Krüger T, Westenfeld R, Mahnken AH, Yagmur E, Boecker G, Heussen N, Gladziwa U, Ketteler M, Weber C, Floege J (2008) Predictors of low circulating endothelial progenitor cell numbers in haemodialysis patients. Nephrol Dial Transplant 23: 2611-2618. doi: 10.1093/ndt/gfn103.
  • Schmidt-Lucke C, Rössig L, Fichtlscherer S, Vasa M, Britten M, Kämper U, Dimmeler S, Zeiher AM (2005) Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111: 2981-2987. doi: 0.1161/CIRCULATIONAHA.104.504340.
  • Sibal L, Aldibbiat A, Agarwal SC, Mitchell G, Oates C, Razvi S, Weaver JU, Shaw JA, Home PD (2009) Circulating endothelial progenitor cells, endothelial function, carotid intima-media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria. Diabetologia 52: 1464-1473. doi: 10.1007/s00125-009-1401-0.
  • Sis B (2012) Endothelial molecules decipher the mechanisms and functional pathways in antibody-mediated rejection. Hum Immunol 73: 1218-1225. doi: 10.1016/j.humimm.2012.07.332.
  • Surdacki A, Martens-Lobenhoffer J, Wloch A, Marewicz E, Rakowski T, Wieczorek-Surdacka E, Dubiel JS, Pryjma J, Bode-Böger SM (2007) Elevated plasma asymmetric dimethyl-L-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis. Arthritis Rheum 56: 809-819. doi: 10.1002/art.22424.
  • Surdacki A, Marewicz E, Wieczorek-Surdacka E, Rakowski T, Szastak G, Pryjma J, Dudek D, Dubiel JS (2010) Synergistic effects of asymmetrical dimethyl-L-arginine accumulation and endothelial progenitor cell deficiency on renal function decline during a 2-year follow-up in stable angina. Nephrol Dial Transplant 25: 2576-2583. doi: 10.1093/ndt/gfp439.
  • Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T (1999) Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5: 434-438. doi: 10.1038/7434.
  • Thum T, Tsikas D, Stein S, Schultheiss M, Eigenthaler M, Anker SD, Poole-Wilson PA, Ertl G, Bauersachs J (2005) Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J Am Coll Cardiol 46: 1693-1701. doi: 10.1016/j.jacc.2005.04.066.
  • Ueno H, Koyama H, Fukumoto S, Tanaka S, Shoji T, Shoji T, Emoto M, Tahara H, Tsujimoto Y, Tabata T, Nishizawa Y (2010) Dialysis modality is independently associated with circulating endothelial progenitor cells in end-stage renal disease patients. Nephrol Dial Transplant 25: 581-586. doi: 10.1093/ndt/gfp358.
  • Urbich C, Heeschen C, Aicher A, Dernbach E, Zeiher AM, Dimmeler S (2003) Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 108: 2511-2516. doi: 10.1161/01.CIR.0000096483.29777.50.
  • Urbich C, Dimmeler S (2004) Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95: 343-353. doi: 10.1161/01.RES.0000137877.89448.78.
  • Vajkoczy P, Blum S, Lamparter M, Mailhammer R, Erber R, Engelhardt B, Vestweber D, Hatzopoulos AK (2003) Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. J Exp Med 197: 1755-1765. doi: 10.1084/jem.20021659.
  • Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S (2001) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89: E1-E7. doi: 10.1161/hh1301.093953.
  • Wang CH, Cherng WJ, Yang NI, Hsu CM, Yeh CH, Lan YJ, Wang JS, Verma S (2008) Cyclosporine increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system. Am J Physiol Regul Integr Comp Physiol 294: R811-R818. doi: 10.1152/ajpregu.00543.2007.
  • Werner N, Junk S, Laufs U, Link A, Walenta K, Bohm M, Nickenig G (2003) Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 93: e17-24. doi: 10.1161/01.RES.0000083812.30141.74.
  • Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M, Nickenig G (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353: 999-1007. doi: 10.1056/NEJMoa043814.
  • Westerweel PE, Hoefer IE, Blankestijn PJ, de Bree P, Groeneveld D, van Oostrom O, Braam B, Koomans HA, Verhaar MC (2007) End-stage renal disease causes an imbalance between endothelial and smooth muscle progenitor cells. Am J Physiol Renal Physiol 292: F1132 -F1140. doi: 10.1152/ajprenal.00163.2006.
  • Xiao Q, Kiechl S, Patel S, Oberhollenzer F, Weger S, Mayr A, Metzler B, Reindl M, Hu Y, Willeit J, Xu Q (2007) Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis - results from a large population-based study. PLoS One 2: e975. doi: 10.1371/journal.pone.0000975.
  • Yu Y, Fukuda N, Yao EH, Matsumoto T, Kobayashi N, Suzuki R, Tahira Y, Ueno T, Matsumoto K (2008) Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension. Am J Hypertens 21: 72-77. doi: 10.1038/ajh.2007.5.
  • Zhao J, Bolton EM, Randle L, Bradley JA, Lever AM (2014) Functional characterization of late outgrowth endothelial progenitor cells in patients with end-stage renal failure. Transpl Int 27: 437-451. doi: 10.1111/tri.12277.
  • Zhu XY, Urbieta Caceres VH, Favreau FD, Krier JD, Lerman A, Lerman LO (2011) Enhanced endothelial progenitor cell angiogenic potency, present in early experimental renovascular hypertension, deteriorates with disease duration. J Hypertens 29: 1972-1979. doi: 10.1097/HJH.0b013e32834ae611.
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.bwnjournal-article-abpv63p475kz
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.